Boston Scientific Corporation Share Price
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.70 USD | +0.18% |
|
-5.96% | +3.78% |
| 12-08 | Why the Fed's Next Move Matters More Than Markets Admit |  |
| 12-08 | Analyst recommendations: 3M Company, Exxon Mobil, Mastercard, Netflix, Tesla… | |
| Capitalization | 137B 118B 110B 103B 190B 12,352B 207B 1,279B 499B 5,855B 516B 505B 21,488B | P/E ratio 2025 * |
44.9x | P/E ratio 2026 * | 36.1x |
|---|---|---|---|---|---|
| Enterprise value | 146B 126B 117B 110B 202B 13,147B 220B 1,362B 531B 6,232B 549B 537B 22,871B | EV / Sales 2025 * |
7.29x | EV / Sales 2026 * | 6.39x |
| Free-Float |
84.69% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | +0.18% | ||
| 1 week | -5.96% | ||
| Current month | -8.74% | ||
| 1 month | -8.14% | ||
| 3 months | -11.91% | ||
| 6 months | -6.68% | ||
| Current year | +3.78% |
| 1 week | 91.86 |  | 98.68 |
| 1 month | 91.86 | | 105.65 |
| Current year | 85.98 | | 109.5 |
| 1 year | 85.98 | | 109.5 |
| 3 years | 44.35 | | 109.5 |
| 5 years | 33.42 | | 109.5 |
| 10 years | 15.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 60 | 31/10/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 51 | 29/06/2025 |
John Sorenson
COO | Chief Operating Officer | 57 | 30/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
John Sununu
BRD | Director/Board Member | 60 | 31/03/2009 |
Michael Mahoney
CHM | Chairman | 60 | 02/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 73 | 28/02/2014 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.75% | 26 M€ | +11.67% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.18% | -5.96% | +2.77% | +100.52% | 137B | |
| +1.91% | -1.14% | +7.08% | +2.42% | 212B | |
| -0.40% | -2.42% | +3.31% | +105.44% | 198B | |
| +3.22% | +0.86% | -1.67% | -14.45% | 158B | |
| -1.23% | +2.08% | -19.26% | -13.55% | 56.88B | |
| +0.77% | -0.07% | +14.35% | +13.39% | 48.33B | |
| +2.01% | -3.88% | +1.09% | -6.20% | 39.81B | |
| +1.73% | +1.05% | +2.56% | - | 37.82B | |
| +2.02% | +0.02% | +2.56% | +14.48% | 35.93B | |
| -0.36% | -0.75% | -24.71% | -36.42% | 34.02B | |
| Average | +0.53% | -1.06% | -1.19% | +18.40% | 95.7B | |
| Weighted average by Cap. | +0.57% | -1.51% | +1.32% | +34.59% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 20.08B 17.24B 16.12B 15.06B 27.79B 1,804B 30.23B 187B 72.83B 855B 75.34B 73.74B 3,139B | 22.37B 19.21B 17.96B 16.78B 30.96B 2,011B 33.69B 208B 81.16B 953B 83.95B 82.17B 3,498B |
| Net income | 3.02B 2.59B 2.42B 2.27B 4.18B 271B 4.55B 28.12B 10.96B 129B 11.33B 11.09B 472B | 3.76B 3.23B 3.02B 2.82B 5.2B 338B 5.66B 34.99B 13.64B 160B 14.1B 13.81B 588B |
| Net Debt | 8.85B 7.6B 7.1B 6.64B 12.24B 795B 13.32B 82.37B 32.09B 377B 33.2B 32.49B 1,383B | 5.45B 4.68B 4.38B 4.09B 7.55B 490B 8.21B 50.77B 19.78B 232B 20.46B 20.03B 853B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/12/25 | 92.70 $ | +0.18% | 11,592,830 |
| 09/12/25 | 92.53 $ | -1.40% | 12,670,425 |
| 08/12/25 | 93.84 $ | -3.77% | 14,721,272 |
| 05/12/25 | 97.52 $ | -0.20% | 8,145,496 |
| 04/12/25 | 97.72 $ | -0.86% | 9,407,689 |
Delayed Quote Nyse, December 10, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition